Mike Gladstone, global president and general manager of Pfizer Inflammation and Immunology unit, said that the acquisition of Arena is in line with the company’s capabilities and expertise in immunology and inflammatory-related conditions. Over the years, Pfizer has successfully created an innovation engine that develops potential medicines for patients worldwide with chronic and debilitating immuno-inflammatory conditions. The company understands that there is an urgent need to look into other treatment options with high potential, which is where Arena’s cannabinoid-drug pipeline comes in.
They smoke an absurd amount of weed, rap about everything from ketamine to pharmaceutical trials,…
A four-person Johns Hopkins pilot study found that 25 mg of oral THC could produce…
He signed it Wednesday. Most of the federal hemp restrictions now take effect December 11…
The founders of LEVIA took opposite paths after selling the brand. What they learned on…
Morrissey, Patti Smith, Interpol, Sex Pistols and generations of punk descend on Brooklyn September 26…
Four years running, a field in Brentwood, California, fills up with people passing joints the…